WeVote
Log In

Bill

Bill

SJR 10

Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (BDR R-801)

2025 Regular Session Introduced by Natha Anderson and 25 co-sponsors

Urge Congress to ease regulation, fund, and accelerate research and access to psychedelic-assisted therapies for PTSD, depression, TBI, and related conditions.

Enrolled and delivered to Secretary of State. File No. 28.
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments

SJR 10_Letters of Support SJR10 Testimony in Support - submitted by Gehrig Tucker SJR10 Testimony in Support - submitted by Dustin Hines SJR10 Testimony in Support - submitted by Diane Goldstein SJR 10_Science Testimony_Burton J Tabaac MD FAHA SJR 10_Testimony_Jon Dalton_President_Nevada Coalition for Psychedelic Medicines SJR10 Work Session Document and Amendment SJR10 Testimony in Support SJR 10_Work Session Document_H. Pepper Sturm_Senior Principal Policy Analyst_LCB Research Division Psychedelic Medicines Working Group Report - from the Department of Health and Human Services, submitted by Jonathan Dalton SJR 10_Testimony_Kate Cotter_Executive Director_Nevada Coalition for Psychedelic Medicines SJR 10_Testimony_Dr Dustin Hines SJR 10_Report of the Psychedelic Medicines Working Group_Marla McDade Williams_Administrator_Division of Child and Family Services_NDHHS